Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Pulmatrix, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| Shares | 511.8K | 424.2K | −87.6K (−17.1%) |
| Value | $1.50M | $1.14M | −$359.5K (−24.0%) |
New holders (1)
Institutions that held Pulmatrix, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 12,113 | $32.0K | 0.00% |
Sold out (3)
Institutions that held Pulmatrix, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 24,907 | $73.5K |
| Citadel Advisors LLC | 15,174 | $44.8K |
| JPMorgan Chase & Co | 100 | $0 |